• A study to evaluate the effectiveness and safety of azetukalner in patients experiencing depressive episodes associated with bipolar disorder.

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Poland Spain

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +5

  • A study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain Sweden

  • Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Latvia Poland +2

  • A Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Poland Spain

  • A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

    Recruiting

    2 1
    Investigated diseases:
    Bulgaria Czechia Germany Hungary Poland

  • A study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Spain

  • A study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Romania

  • Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Estonia +12

  • A study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

powered by